Sickle Cell Anemia Research Today is a free monthly online journal that collates and summarizes the latest research about Sickle Cell Anemia, including details on genetics, causes, symptoms.

Volume 5 (2010), Issue 10 (October)

1. Plasma levels of advanced glycation end products are associated with haemolysis-related organ complications in sickle cell patients.
   Br J Haematol, 151(1): 62-9. [Abstract] [Full-text]
2. Pulmonary complications of hemoglobinopathies.
   Chest, 138(4): 973-83. [Abstract] [Full-text]
3. Effect of oral arginine supplementation on exhaled nitric oxide concentration in sickle cell anemia and acute chest syndrome.
   J Pediatr Hematol Oncol, 32(7): e249-58. [Abstract] [Full-text]
4. Impact of clinical pathway on quality of care in sickle cell patients.
   J Pediatr Hematol Oncol, 32(7): 537-9. [Abstract] [Full-text]
5. A family-based randomized controlled trial of pain intervention for adolescents with sickle cell disease.
   J Pediatr Hematol Oncol, 32(7): 540-7. [Abstract] [Full-text]
6. A new sickling variant 'Hb S-Wake β[(Glu6Val-Asn139 Ser)]' found in a compound heterozygote with Hb S β(Glu6Val) coinherited with homozygous α-thalassemia-2: phenotype and molecular characteristics.
   Acta Haematol, 124(2): 120-4. [Abstract] [Full-text]
7. Facial features of patients with sickle cell anemia.
   Angle Orthod, 81(1): 115-20. [Abstract] [Full-text]
8. RH genotyping in a sickle cell disease patient contributing to hematopoietic stem cell transplantation donor selection and management.
   Blood, 116(15): 2836-8. [Abstract] [Full-text]
9. Sickle cell disease resulting from uniparental disomy in a child who inherited sickle cell trait.
   Blood, 116(15): 2822-5. [Abstract] [Full-text]
10. Complete response to carboplatin, gemcitabine, and paclitaxel in a patient with advanced metastatic renal medullary carcinoma.
    Pediatr Blood Cancer, 55(6): 1217-20. [Abstract] [Full-text]
11. Antibody development in pediatric sickle cell patients undergoing erythrocytapheresis.
    Pediatr Blood Cancer, 55(6): 1134-7. [Abstract] [Full-text]
12. Complete response to carboplatin, gemcitabine, and paclitaxel in a patient with advanced metastatic renal medullary carcinoma.
    Pediatr Blood Cancer, 55(6): 1217-20. [Abstract] [Full-text]
13. Antibody development in pediatric sickle cell patients undergoing erythrocytapheresis.
    Pediatr Blood Cancer, 55(6): 1134-7. [Abstract] [Full-text]
14. Complete response to carboplatin, gemcitabine, and paclitaxel in a patient with advanced metastatic renal medullary carcinoma.
    Pediatr Blood Cancer, 55(6): 1217-20. [Abstract] [Full-text]
15. Antibody development in pediatric sickle cell patients undergoing erythrocytapheresis.
    Pediatr Blood Cancer, 55(6): 1134-7. [Abstract] [Full-text]
16. Safety and efficacy of high dose intravenous desferrioxamine for reduction of iron overload in sickle cell disease.
    Pediatr Blood Cancer, 55(7): 1338-42. [Abstract] [Full-text]
17. Safety and efficacy of high dose intravenous desferrioxamine for reduction of iron overload in sickle cell disease.
    Pediatr Blood Cancer, 55(7): 1338-42. [Abstract] [Full-text]
18. Safety and efficacy of high dose intravenous desferrioxamine for reduction of iron overload in sickle cell disease.
    Pediatr Blood Cancer, 55(7): 1338-42. [Abstract] [Full-text]

© 2006-2012 Sickle Cell Anemia Research Today. All Rights Reserved.